Suppr超能文献

早期宫颈癌患者的微创手术与腹式根治性子宫切除术:一项荟萃分析。

Minimally invasive surgery and abdominal radical hysterectomy in patients with early-stage cervical cancer: A meta-analysis.

作者信息

Yu Yuanyi, Deng Ting, Gu Shequn

机构信息

Department of Gynecology, The First People's Hospital of Chenzhou, Hunan, China.

Department of Oncology, The First People's Hospital of Chenzhou, Hunan, China.

出版信息

Int J Gynaecol Obstet. 2022 May;157(2):255-264. doi: 10.1002/ijgo.13796. Epub 2021 Jul 18.

Abstract

OBJECTIVE

To compare risk of recurrence and death related to minimally invasive surgery (MIS) and abdominal radical hysterectomy (ARH) in early-stage cervical cancer (CC) patients.

METHODS

All relevant literatures in databases were retrieved from the built time of databases to October 2020. Observational studies comparing MIS and ARH in early-stage CC patients were involved. Newcastle-Ottawa Scale was used for quality assessment, including studies with a score of at least 6. Main outcomes involved overall survival (OS) and disease-free survival (DFS).

RESULTS

Twenty-two studies were involved, including 14 894 patients, among which 7213 (48.6%) underwent MIS. The OS (hazard ratio [HR] 1.23, 95% confidence interval [CI] 1.03-1.43) and DFS (HR 1.25, 95% CI 1.07-1.42) of patients undergoing MIS was obviously shortened compared with those of patients undergoing ARH. Subgroup analysis revealed that OS (HR 1.42, 95% CI 1.10-1.74) and DFS (HR 1.46, 95% CI 1.18-1.74) of patients with a tumor ≥2 cm in diameter were significantly reduced by MIS.

CONCLUSION

Overall survival and DFS after MIS for early-stage CC treatment were worse than those after ARH, especially for patients with a tumor ≥2 cm in diameter.

摘要

目的

比较早期宫颈癌(CC)患者中,微创外科手术(MIS)和腹式广泛性子宫切除术(ARH)相关的复发风险和死亡风险。

方法

检索数据库中自建库时间至2020年10月的所有相关文献。纳入比较早期CC患者中MIS和ARH的观察性研究。采用纽卡斯尔-渥太华量表进行质量评估,纳入得分至少为6分的研究。主要结局包括总生存期(OS)和无病生存期(DFS)。

结果

共纳入22项研究,涉及14894例患者,其中7213例(48.6%)接受了MIS。与接受ARH的患者相比,接受MIS的患者OS(风险比[HR]1.23,95%置信区间[CI]1.03-1.43)和DFS(HR 1.25,95% CI 1.07-1.42)明显缩短。亚组分析显示,直径≥2 cm肿瘤患者接受MIS后,OS(HR 1.42,95% CI 1.10-1.74)和DFS(HR 1.46,95% CI 1.18-1.74)显著降低。

结论

早期CC治疗中,MIS后的总生存期和DFS比ARH后的更差,尤其是对于直径≥2 cm肿瘤的患者。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验